Imricor receives CE Mark certification for the Advantage-MR system under new European Medical Device Regulation as it hits ...

Johnson & Johnson’s electrophysiology unit struggled in the first quarter, as the company chases Medtronic and Boston ...

Jackson-Madison County General Hospital now offers a new therapy to treat patients with advanced atrial fibrillation, who ...

Ablation of the posterior nasal nerve leads to durable reductions in symptoms of chronic rhinitis, new research shows.

The global cryoballoon ablation system market is on an impressive growth trajectory, with recent forecasts projecting its value to reach USD 1.8 billion by 2033, up from an estimated USD 1.1 billion ...

Pulse Biosciences is developing nsPFA technology for cardiac ablation to treat AFib and for ablating benign thyroid nodules.

Researchers from Queen Mary University of London have developed an AI tool that creates synthetic yet medically accurate ...

Innoblative Designs announced today that it received FDA investigational device exemption (IDE) for its Sira RFA ...

South Jordan, Utah–based Merit adds the latest delivery system to its growing electrophysiology (EP) and cardiac rhythm management (CRM) portfolio. It joins solutions such as HeartSpan, Worley, ...

The NeuroOne OneRF Ablation System is a new device with FDA-cleared technology designed for both diagnosing and treating ...

See how Pulse Biosciences, Inc.'s stock surged 100% despite no clear commercialization timeline, management turnover, and ...